CD8A and neoplasm: Paradoxically, docetaxel-based therapy has proven clinically favorable in remodeling the TME, with paired pre- and post-therapy tumor samples showing statistically significant increases in CD8+ T-cell infiltration for patients with locally advanced PCa 153.